Dual impact of Ashwagandha: Significant cortisol reduction but no effects on perceived stress - A systematic review and meta-analysis.

IF 1.4 Q3 NUTRITION & DIETETICS
Ahmad Abdualrazag Albalawi
{"title":"Dual impact of Ashwagandha: Significant cortisol reduction but no effects on perceived stress - A systematic review and meta-analysis.","authors":"Ahmad Abdualrazag Albalawi","doi":"10.1177/02601060251363647","DOIUrl":null,"url":null,"abstract":"<p><p>BackgroundThe global medicine market is projected to reach US$417 billion by 2033, reflecting rising demand for natural healthcare alternatives. Ashwagandha (<i>Withania somnifera</i>) is widely used in Ayurvedic medicine for stress management, but evidence supporting its efficacy remains inconsistent.AimThis systematic review and meta-analysis evaluated Ashwagandha's impact on cortisol levels (a biological stress marker) and perceived stress via Perceived Stress Scale (PSS) scores across randomized controlled trials (RCTs).MethodPRISMA guidelines were followed. Four databases (PubMed, CINAHL, Google Scholar, and Scopus) were searched for studies from January 2012 to February 2024, yielding seven studies on cortisol and six on perceived stress (<i>n</i> = 488 participants). Inclusion criteria were RCTs longer than or equal to two weeks, oral doses ≥250 mg/day, and reporting cortisol and PSS outcomes. The Cochrane Risk of Bias 2 tool was used to assess the risk of bias.ResultsThere was a statistically significant reduction in cortisol levels (-1.16 µg/dL, 95% CI: -1.64 to -0.69, <i>P</i> < 0.001). No significant impact was observed on perceived stress (SMD = -0.355, 95% CI: -1.188 to 0.47; <i>P</i> = 0.40). Heterogeneity was moderate (<i>I</i><sup>2</sup> = 50.9%). However, no statistically significant impact was observed on perceived stress (SMD = -0.355, 95% CI: -1.188 to 0.47; <i>P</i>-value = 0.40). The heterogeneity among studies was moderate (<i>I</i><sup>2</sup> = 50.9%). Risk of bias was generally moderate; most studies reported adequate randomization, but some lacked allocation concealment. No publication bias was detected.ConclusionFindings support Ashwagandha's role in lowering cortisol, but gaps remain regarding long-term safety, dosing, and effectiveness across diverse populations. The disconnect between cortisol and PSS outcomes highlights the need for longer treatment duration and broader demographic inclusion. Longitudinal research is recommended to validate Ashwagandha as a holistic stress management tool.</p>","PeriodicalId":19352,"journal":{"name":"Nutrition and health","volume":" ","pages":"2601060251363647"},"PeriodicalIF":1.4000,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nutrition and health","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/02601060251363647","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"NUTRITION & DIETETICS","Score":null,"Total":0}
引用次数: 0

Abstract

BackgroundThe global medicine market is projected to reach US$417 billion by 2033, reflecting rising demand for natural healthcare alternatives. Ashwagandha (Withania somnifera) is widely used in Ayurvedic medicine for stress management, but evidence supporting its efficacy remains inconsistent.AimThis systematic review and meta-analysis evaluated Ashwagandha's impact on cortisol levels (a biological stress marker) and perceived stress via Perceived Stress Scale (PSS) scores across randomized controlled trials (RCTs).MethodPRISMA guidelines were followed. Four databases (PubMed, CINAHL, Google Scholar, and Scopus) were searched for studies from January 2012 to February 2024, yielding seven studies on cortisol and six on perceived stress (n = 488 participants). Inclusion criteria were RCTs longer than or equal to two weeks, oral doses ≥250 mg/day, and reporting cortisol and PSS outcomes. The Cochrane Risk of Bias 2 tool was used to assess the risk of bias.ResultsThere was a statistically significant reduction in cortisol levels (-1.16 µg/dL, 95% CI: -1.64 to -0.69, P < 0.001). No significant impact was observed on perceived stress (SMD = -0.355, 95% CI: -1.188 to 0.47; P = 0.40). Heterogeneity was moderate (I2 = 50.9%). However, no statistically significant impact was observed on perceived stress (SMD = -0.355, 95% CI: -1.188 to 0.47; P-value = 0.40). The heterogeneity among studies was moderate (I2 = 50.9%). Risk of bias was generally moderate; most studies reported adequate randomization, but some lacked allocation concealment. No publication bias was detected.ConclusionFindings support Ashwagandha's role in lowering cortisol, but gaps remain regarding long-term safety, dosing, and effectiveness across diverse populations. The disconnect between cortisol and PSS outcomes highlights the need for longer treatment duration and broader demographic inclusion. Longitudinal research is recommended to validate Ashwagandha as a holistic stress management tool.

Ashwagandha的双重影响:显著降低皮质醇,但对感知压力没有影响——一项系统回顾和荟萃分析。
到2033年,全球医药市场预计将达到4170亿美元,反映出对天然保健替代品的需求不断增长。Ashwagandha (Withania somnifera)在阿育吠陀医学中广泛用于压力管理,但支持其功效的证据仍然不一致。目的本系统综述和荟萃分析通过随机对照试验(rct)的感知应激量表(PSS)评分评估了Ashwagandha对皮质醇水平(生物应激标志物)和感知应激的影响。方法遵循prisma指南。4个数据库(PubMed, CINAHL, b谷歌Scholar和Scopus)检索了2012年1月至2024年2月的研究,获得了7项关于皮质醇的研究和6项关于感知压力的研究(n = 488名参与者)。纳入标准为rct时间大于或等于两周,口服剂量≥250mg /天,并报告皮质醇和PSS结果。采用Cochrane Risk of Bias 2工具评估偏倚风险。结果皮质醇水平降低具有统计学意义(-1.16µg/dL, 95% CI: -1.64 ~ -0.69, P = 0.40)。异质性为中等(I2 = 50.9%)。然而,在感知压力方面没有观察到统计学上显著的影响(SMD = -0.355, 95% CI: -1.188 ~ 0.47;p值= 0.40)。研究间异质性为中等(I2 = 50.9%)。偏倚风险一般为中等;大多数研究报告了充分的随机化,但有些缺乏分配隐蔽性。未发现发表偏倚。结论:研究结果支持Ashwagandha在降低皮质醇方面的作用,但在不同人群的长期安全性、剂量和有效性方面仍存在差距。皮质醇和PSS结果之间的脱节强调了需要更长的治疗时间和更广泛的人口统计学纳入。建议进行纵向研究以验证Ashwagandha作为整体压力管理工具的有效性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Nutrition and health
Nutrition and health Medicine-Medicine (miscellaneous)
CiteScore
3.50
自引率
0.00%
发文量
160
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信